Related references
Note: Only part of the references are listed.Low-Molecular-Weight Heparin and Fondaparinux Use in Pediatric Patients With Obesity
Michael P. Garner et al.
ANNALS OF PHARMACOTHERAPY (2021)
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness
Neil A. Goldenberg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
NONMEM Tutorial Part I: Description of Commands and Options, With Simple Examples of Population Analysis
Robert J. Bauer
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Population Pharmacokinetics of Enoxaparin in Pediatric Patients
Brady S. Moffett et al.
ANNALS OF PHARMACOTHERAPY (2018)
Allometric size: The scientific theory and extension to normal fat mass
Nick H. G. Holford et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Enoxaparin Population Pharmacokinetics in the First Year of Life
Brady S. Moffett et al.
THERAPEUTIC DRUG MONITORING (2017)
Comparison of Anti-Xa Levels in Obese and Non-Obese Pediatric Patients Receiving Treatment Doses of Enoxaparin
Ashley A. Richard et al.
JOURNAL OF PEDIATRICS (2013)
Safe and Effective Variability-A Criterion for Dose Individualization
Nicholas H. G. Holford et al.
THERAPEUTIC DRUG MONITORING (2012)
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model
L. I. Cortinez et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Solving Differential Equations in R: Package deSolve
Karline Soetaert et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Individualized compared with conventional dosing of enoxaparin
M. A. Barras et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Hirsh et al.
CHEST (2004)
Perls-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome
C Macie et al.
CHEST (2004)
Share Paper
